MedTrace Logo

Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip

NCT02941666 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-12-12

No results posted yet for this study

Summary

Previous studies have shown an increase in the concentration of mesenchymal stem cells (MSC's) in the setting of osteoarthritis of the knee and its correlation to severity. Researchers have shown that as there is an increase in the severity of the disease, the concentration of stem cells also increases. The purpose of this study is to determine if there is the same increase in stem cell concentration in patients with osteonecrosis (ON) of the femoral head.

Conditions

  • Osteonecrosis

Sponsors & Collaborators

Principal Investigators

  • Raphael J. Sierra, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02941666 on ClinicalTrials.gov